Emergency ContraceptionNCT04172584
Awareness & Use of Emergency Contraception
An observational study of Emergency Contraception, run by Assiut University.
Trial summary
General objective: To decrease the percentage of unwanted and/or unplanned pregnancies and their consequences on women's reproductive health. Specific objectives: 1. To assess awareness of the study participants about emergency contraception. 2. Determine the percentage of ever use among the participants. 3. Read more about this study
- Who is it for?
- Ages 15 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Emergency Contraception
- What is being tested?
- correct use of the contraceptions
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 400 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 2019to 1 Jan 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 45 years
- Women only
- Healthy volunteers accepted
- Child, Adult
Study population: Married women in reproductive age (15 - 49 years) clients who are attending Kidwany MCH centre, Assiut city.
Who may be able to join
- Married women in reproductive age (15 - 49 years)
Who cannot join
- Infertile and postmenopausal women.
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Awareness & Use of Emergency Contraception Among Women Attending Kidwany MCH Center , Assiut City
General objective:
To decrease the percentage of unwanted and/or unplanned pregnancies and their consequences on women's reproductive health.
Specific objectives:
- To assess awareness of the study participants about emergency contraception.
- Determine the percentage of ever use among the participants.
- To identify factors that affect the awareness and use of emergency contraception among the study participants
- Conditions
- Emergency Contraception
- Being tested
- correct use of the contraceptions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
correct use of the contraceptionsBehavioural
know the emergency contraception and how to use
What is being measured
The primary outcome is the main question the study is designed to answer.
Percent of awareness and use of emergency contraception
when to use emergency contraception to prevent the unwanted pregnancy
Measured: baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2019
- Study start1 Dec 2019 (estimated)
- Primary completion1 Dec 2020 (estimated)
- Study completion1 Jan 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Emergency ContraceptionStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marian Agaiby Ashem, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04172584
- Sponsor's protocol ID
- Emergency contraception.
- Status last verified
- Nov 2019
- First submitted
- 19 Nov 2019
- Last updated
- 21 Nov 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Mohammed S, Abdulai AM, Iddrisu OA. Pre-service knowledge, perception, and use of emergency contraception among future healthcare providers in northern Ghana. Contracept Reprod Med. 2019 Jan 24;4:1. doi: 10.1186/s40834-018-0082-9. eCollection 2019.
PubMed 30693098Mittal S. Emergency contraception: which is the best? Minerva Ginecol. 2016 Dec;68(6):687-99. Epub 2016 Apr 15.
PubMed 27082029Association of Women's Health, Obstetric and Neonatal Nurses. Emergency Contraception. J Obstet Gynecol Neonatal Nurs. 2017 Nov-Dec;46(6):886-888. doi: 10.1016/j.jogn.2017.09.004. No abstract available.
PubMed 29128088
Study at a glance
From the registry record, last updated by the sponsor on 21 Nov 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Awareness & Use of Emergency Contraception Among Women Attending Kidwany MCH Center , Assiut City
- ClinicalTrials.gov ID
- NCT04172584
- Acronym / sponsor ID
- Emergency contraception.
- Conditions
- Emergency Contraception
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Dec 2019 (estimated)
- Primary completion
- 1 Dec 2020 (estimated)
- Study completion
- 1 Jan 2021 (estimated)
- First posted
- 21 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
General objective:
To decrease the percentage of unwanted and/or unplanned pregnancies and their consequences on women's reproductive health.
Specific objectives:
- To assess awareness of the study participants about emergency contraception.
- Determine the percentage of ever use among the participants.
- To identify factors that affect the awareness and use of emergency contraception among the study participants
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 15 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Married women in reproductive age (15 - 49 years) clients who are attending Kidwany MCH centre, Assiut city.
Key inclusion criteria (1 listed)
- Married women in reproductive age (15 - 49 years)
Key exclusion criteria (1 listed)
- Infertile and postmenopausal women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| correct use of the contraceptionsknow the emergency contraception and how to use | Behavioural | – |
Primary outcome
Percent of awareness and use of emergency contraception
Time frame: baseline
when to use emergency contraception to prevent the unwanted pregnancy
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Nov 2019.
- Background: PubMed 30693098Mohammed S, Abdulai AM, Iddrisu OA. Pre-service knowledge, perception, and use of emergency contraception among future healthcare providers in northern Ghana. Contracept Reprod Med. 2019 Jan 24;4:1. doi: 10.1186/s40834-018-0082-9. eCollection 2019.
- Results publication: PubMed 27082029Mittal S. Emergency contraception: which is the best? Minerva Ginecol. 2016 Dec;68(6):687-99. Epub 2016 Apr 15.
- Results publication: PubMed 29128088Association of Women's Health, Obstetric and Neonatal Nurses. Emergency Contraception. J Obstet Gynecol Neonatal Nurs. 2017 Nov-Dec;46(6):886-888. doi: 10.1016/j.jogn.2017.09.004. No abstract available.
Related trials for Emergency Contraception
Recruiting
The Influence of Plan B® on Cardiovascular Health.
Female, Premenopausal
RecruitingPhase 4
Etonogestrel Implant as Emergency Contraception
Contraception
RecruitingPhase 4
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
Contraceptive Usage
RecruitingPhase 4
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Emergency Contraception
RecruitingPhase 3
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
Contraception
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Emergency Contraception, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marian Agaiby, doctor (01200612264, agaiby49@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percent of awareness and use of emergency contraception (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04172584, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2019.